Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
BMC Infectious Diseases 2013, 13:75 doi:10.1186/1471-2334-13-75
This article is currently available as a provisional PDF. Reprints are produced from the final PDF, which is normally produced within 3 weeks.
Please complete the following form to register your interest in ordering reprints of this article. BioMed Central will contact you by email when the final PDF is available with details of how to obtain a quotation and place an order.
Fields marked * are required